Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x)

Luz M. Canet, Jose M. Sánchez-Maldonado, Rafael Cáliz, Ana Rodríguez-Ramos, Carmen B. Lupiañez, Helena Canhão, Manuel Martínez-Bueno, Alejandro Escudero, Juana Segura-Catena, Signe B. Sorensen, Merete L. Hetland, María José Soto-Pino, Miguel A. Ferrer, Antonio García, Bente Glintborg, Ileana Filipescu, Eva Pérez-Pampin, Alfonso González-Utrilla, Miguel Ángel López Nevot, Pablo Conesa-ZamoraAlfons den Broeder, Salvatore De Vita, Sven Erik Hobe Jacobsen, Eduardo Collantes-Estevez, Luca Quartuccio, Federico Canzian, João E. Fonseca, Marieke J.H. Coenen, Vibeke Andersen, Juan Sainz*

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Abstrakt

The original version of this Article contained an error in the spelling of the author Ana Rodríguez-Ramos, which was incorrectly given as Ana Rodríguez Ramos. This has now been corrected in both the PDF and HTML versions of the Article.

OriginalsprogEngelsk
TidsskriftPharmacogenomics Journal
Vol/bind19
Sider (fra-til)582
Antal sider1
ISSN1470-269X
DOI
StatusUdgivet - 1. jan. 2019

Fingeraftryk Dyk ned i forskningsemnerne om 'Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x)'. Sammen danner de et unikt fingeraftryk.

Citationsformater